Gilead Sciences Inc. (NASDAQ:GILD) on Wednesday agreed to acquire Repare Therapeutics Inc.’s (NASDAQ:RPTX) polymerase theta (Polθ) ATPase inhibitor, RP-3467. RP-3467 is being evaluated in the POLAR Phase 1 trial to evaluate its safety, pharmacokinetics, pharmacodynamics, and preliminary activity alone or…
PowerBank Corporation (NASDAQ:SUUN) stock rose Wednesday after it received an initial $4 million payment for the previously announced Elmira, Jordan Road 1, and Jordan Road 2 projects. The company expects the remaining portion of the $41 million transaction as construction…
Although semiconductor juggernaut Nvidia Corp. (NASDAQ:NVDA) has become practically synonymous with the dramatic rise in artificial intelligence, the tremendous success also serves as a point of caution. True, NVDA stock has skyrocketed in recent years on the back of its…
Gainers Symbol Name Price Change ($) Change (%) Volume (NYSE:XLB) State Street Materials Select Sector SPDR ETF 45.86 0.11 0.24 604 (NYSE:XLRE) State Street Real Estate Select Sector SPDR ETF 40.26 0.08 0.19 375 (NYSE:XLU) State Street Utilities Select Sector…
U.S. stock futures were mostly lower this morning, with the Nasdaq 100 futures slipping around 0.1% on Wednesday. Shares of SeaStar Medical Holding Corp (NASDAQ:ICU) fell sharply in pre-market trading after the company announced a 1-for-10 reverse split. SeaStar Medical…
Daktronics, Inc. (NASDAQ:DAKT) on Tuesday announced the acquisition of intellectual property, equipment assets, and technical expertise from X Display Company Technology Limited (XDC), a specialist in mass-transfer processes and MicroLED technology. Financial terms were not disclosed. The Brookings, South Dakota–based…
Inhibrx (NASDAQ:INBX) has staged a sharp rally after reporting positive topline results from its registrational trial of Ozekibart (INBRX-109) back in October 2025. The stock surged more than 150% in a short span, drawing significant investor attention. However, when the…
The U.S. Food and Drug Administration (FDA) on Tuesday approved Agios Pharmaceuticals, Inc.’s (NASDAQ:AGIO) Aqvesme (mitapivat), an oral pyruvate kinase (PK) activator, for anemia in adults with alpha- or beta-thalassemia, a rare type of blood disorder that impacts hemoglobin production.…
Snowflake Inc. (NYSE:SNOW) is in talks to acquire application monitoring startup Observe Inc. for about $1 billion. The Information reported the potential deal on Wednesday, though the transaction has not yet been finalized. Observe offers a modern observability platform built…
Gainers Surgepays (NASDAQ:SURG) stock rose 4.3% to $1.93 during Wednesday's pre-market session. The company's market cap stands at $38.9 million. Fangdd Network Group (NASDAQ:DUO) shares moved upwards by 4.21% to $1.73. The market value of their outstanding shares is at…